InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.430
+0.090 (6.72%)
At close: Dec 5, 2025, 4:00 PM EST
1.360
-0.070 (-4.90%)
After-hours: Dec 5, 2025, 7:57 PM EST
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $5.66 million as of December 5, 2025. Its market cap has increased by 88.50% in one year.
Market Cap
5.66M
Enterprise Value
-3.08M
1-Year Change
88.50%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $5.66M, a decrease of -78.25%. That is a compound annual growth rate of -26.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.80M | 11.76% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.37B |
| Johnson & Johnson | 487.62B |
| AbbVie | 402.86B |
| UnitedHealth Group | 298.70B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 251.01B |
| Abbott Laboratories | 216.70B |